Pathophysiology Program, Lovelace Biomedical Research Institute, Albuquerque, New Mexico, United States of America.
Department of Exercise Physiology, Beijing Sport University, Beijing, China.
PLoS One. 2021 Feb 2;16(2):e0246375. doi: 10.1371/journal.pone.0246375. eCollection 2021.
Prostaglandin E2 (PGE2)-induced coughs in vivo and vagal nerve depolarization in vitro are inhibited by systemic and local administration of prostaglandin EP3 receptor (L-798106) and TRPV1 antagonists (JNJ 17203212). These results indicate a modulating effect of TRPV1 on the EP3 receptor-mediated cough responses to PGE2 likely through the vagal sensory nerve. This study aimed to determine whether 1) inhalation of aerosolized JNJ 17203212 and L-798106 affected cough responses to citric acid (CA, mainly stimulating TRPV1) and PGE2; 2) TRPV1 and EP3 receptor morphologically are co-expressed and electrophysiologically functioned in the individual of vagal pulmonary C-neurons (cell bodies of bronchopulmonary C-fibers in the nodose/jugular ganglia); and 3) there was a cross-effect of TRPV1 and EP3 receptor on these neural excitations. To this end, aerosolized CA or PGE2 was inhaled by unanesthetized guinea pigs pretreated without or with each antagonist given in aerosol form. Immunofluorescence was applied to identify the co-expression of TRPV1 and EP3 receptor in vagal pulmonary C-neurons (retrogradely traced by DiI). Whole-cell voltage patch clamp approach was used to detect capsaicin (CAP)- and PGE2-induced currents in individual vagal pulmonary C-neurons and determine the effects of the TRPV1 and EP3 receptor antagonists on the evoked currents. We found that PGE2-induced cough was attenuated by JNJ 17203212 or L-798106 and CA-evoked cough greatly suppressed only by JNJ 17203212. Approximately 1/4 of vagal pulmonary C-neurons co-expressed EP3 with a cell size < 20 μm. Both CAP- and PGE2-induced currents could be recorded in the individuals of some vagal pulmonary C-neurons. The former was largely inhibited only by JNJ 17203212, while the latter was suppressed by JNJ 17203212 or L-798106. The similarity of the cross-effect of both antagonists on cough and vagal pulmonary C-neural activity suggests that a subgroup of vagal pulmonary C-neurons co-expressing TRPV1 and EP3 receptor is, at least in part, responsible for the cough response to PGE2.
前列腺素 E2(PGE2)在体内诱导的咳嗽和体外迷走神经去极化可被全身和局部给予前列腺素 EP3 受体(L-798106)和 TRPV1 拮抗剂(JNJ 17203212)抑制。这些结果表明 TRPV1 对 PGE2 介导的 EP3 受体咳嗽反应具有调节作用,可能通过迷走感觉神经。本研究旨在确定:1)吸入雾化 JNJ 17203212 和 L-798106 是否会影响柠檬酸(CA,主要刺激 TRPV1)和 PGE2 引起的咳嗽反应;2)TRPV1 和 EP3 受体在个体迷走肺 C 神经元(结状神经节/颈静脉神经节中的支气管肺 C 纤维的细胞体)中是否共表达并且在电生理上起作用;3)TRPV1 和 EP3 受体对这些神经兴奋有交叉作用。为此,未麻醉的豚鼠在预处理时未给予或给予气雾剂形式的每种拮抗剂,然后吸入雾化 CA 或 PGE2。免疫荧光法用于鉴定迷走肺 C 神经元中 TRPV1 和 EP3 受体的共表达(通过 DiI 逆行追踪)。全细胞膜片钳技术用于检测单个迷走肺 C 神经元中辣椒素(CAP)和 PGE2 诱导的电流,并确定 TRPV1 和 EP3 受体拮抗剂对诱发电流的影响。我们发现,PGE2 诱导的咳嗽被 JNJ 17203212 或 L-798106 减弱,而 CA 诱发的咳嗽仅被 JNJ 17203212 大大抑制。约 1/4 的迷走肺 C 神经元共表达 < 20μm 的 EP3。在一些迷走肺 C 神经元中均可记录到 CAP 和 PGE2 诱导的电流。前者主要仅被 JNJ 17203212 抑制,而后者被 JNJ 17203212 或 L-798106 抑制。两种拮抗剂对咳嗽和迷走肺 C 神经元活性的交叉作用相似,表明至少部分共表达 TRPV1 和 EP3 受体的迷走肺 C 神经元亚群负责 PGE2 引起的咳嗽反应。